Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis ; volume:103 ; number:8 ; day:25 ; month:6 ; year:2024 ; pages:3071-3081 ; date:8.2024
Annals of hematology ; 103, Heft 8 (25.6.2024), 3071-3081, 8.2024
- Urheber
-
Denk, Alexander
Edinger, Matthias
Weber, Daniela
Holler, Ernst
Fante, Matthias
Meedt, Elisabeth
Gunes, Sibel
Poeck, Hendrik
Mittermaier, Cornelia
Herr, Wolfgang
Wolff, Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-024-05696-x
- URN
-
urn:nbn:de:101:1-2410122109225.183909587907
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Denk, Alexander
- Edinger, Matthias
- Weber, Daniela
- Holler, Ernst
- Fante, Matthias
- Meedt, Elisabeth
- Gunes, Sibel
- Poeck, Hendrik
- Mittermaier, Cornelia
- Herr, Wolfgang
- Wolff, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease: A Giant Leap-To Start with Baby Steps
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
Endothelial dysfunction during Graft-versus-Host Disease
Prognosefaktoren der chronischen Graft-versus-Host Krankheit
Ruxolitinib in Glucocorticoid Refractory Chronic Graft versus Host Disease
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
Acute Graft-Versus-Host Disease of the Esophagus
A Case of Colonic Graft-versus-Host Disease
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease: A Giant Leap-To Start with Baby Steps
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
Endothelial dysfunction during Graft-versus-Host Disease
Prognosefaktoren der chronischen Graft-versus-Host Krankheit
Ruxolitinib in Glucocorticoid Refractory Chronic Graft versus Host Disease
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
Acute Graft-Versus-Host Disease of the Esophagus
A Case of Colonic Graft-versus-Host Disease
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease: A Giant Leap-To Start with Baby Steps
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
Endothelial dysfunction during Graft-versus-Host Disease
Prognosefaktoren der chronischen Graft-versus-Host Krankheit
Ruxolitinib in Glucocorticoid Refractory Chronic Graft versus Host Disease
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
Acute Graft-Versus-Host Disease of the Esophagus